[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Acelrx Pharmaceutica (ACRX)

Acelrx Pharmaceutica (ACRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
AcelRx Pharmaceuticals: Q3 Earnings Snapshot

AcelRx Pharmaceuticals: Q3 Earnings Snapshot

ACRX : 0.8600 (+7.50%)
AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals: Q2 Earnings Snapshot

AcelRx Pharmaceuticals: Q2 Earnings Snapshot

ACRX : 0.8600 (+7.50%)
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Capital raise closed in July, led by new healthcare investors; provides access to up to $26.3 million in capital, with $10 million immediately available AcelRx...

ACRX : 0.8600 (+7.50%)
AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx" or the "Company"), a specialty pharmaceutical company focused on the development and...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx" or the "Company"), a specialty pharmaceutical company focused on the development and...

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals: Q1 Earnings Snapshot

AcelRx Pharmaceuticals: Q1 Earnings Snapshot

ACRX : 0.8600 (+7.50%)
AcelRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...

ACRX : 0.8600 (+7.50%)
AcelRx to Host First Quarter 2023 Financial Results Call and Webcast on May 10, 2023

/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...

ACRX : 0.8600 (+7.50%)

Barchart Exclusives

This Micro-Cap Penny Stock Just Locked in a Massive AI Data Center Deal
CleanCore Solutions just signed a 10-year deal with Cerebras Systems worth up to $3 billion, fueling its AI data center push. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.